ThGM Cells in CNS Autoimmunity
中枢神经系统自身免疫中的 ThGM 细胞
基本信息
- 批准号:10299105
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-12 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAutoimmuneAutoimmune DiseasesAutoimmunityBiologyBloodBrainCCL20 geneCD4 Positive T LymphocytesCNS autoimmunityCell LineageCell ShapeCellsCellular biologyCerebrospinal FluidClassificationComplexDataDevelopmentDiseaseExperimental Autoimmune EncephalomyelitisFutureGene Expression ProfileHealthHumanImmuneImmunityIn VitroIndividualInflammationInterleukin-2Knockout MiceKnowledgeLeadLesionMediator of activation proteinMembraneModelingMultiple SclerosisMultiple Sclerosis LesionsMusMyeloid CellsNamesNaturePathogenesisPathogenicityPeripheral Blood Mononuclear CellPhenotypePhysiologicalPlayPopulationProcessProductionProteomePublishingRoleShapesSliceSystemT-LymphocyteTNF geneTNFSF6 geneTestingTimecytokinedifferential expressionimmune system functionin vivoknock-downmultiple sclerosis patientneuroinflammationnovel therapeutic interventionnovel therapeuticsoverexpressionsingle-cell RNA sequencingtranscription factortranscriptome
项目摘要
SUMMARY ThGM Cells in CNS Autoimmunity
ThGM cells (ThGM-CSF) are a newly described Th subset characterized by production of GM-CSF, but
lacking expression of signature cytokines and master transcription factors (TF) for established Th cell
lineages. In our analysis, ThGM cells were notably more abundant than Th2 and Th17 cells in the blood of
healthy subjects, and even more so in MS patients. Although ThGM cells have some features of a distinct
lineage, further study is needed to clarify that distinction, as well as their roles in health and disease. ThGM cells
were highly encephalitogenic in the adoptive EAE model, and they can be readily found in the CNS of mice
with direct EAE. Importantly, ThGM cells were enriched in the cerebrospinal fluid of MS patients, who also
have greater numbers of circulating ThGM cells than healthy individuals. These findings suggest that ThGM
cells contribute to the pathogenesis of CNS autoimmunity, but this subject has been only minimally studied. Over
all, our data and published findings led us to hypothesize that ThGM cells play a significant pathogenic role
in autoimmune neuroinflammation, MS and EAE. We will test this hypothesis in the following specific aims:
Aim 1. To determine the origin of ThGM cells, and characterize the relationship between their GM-CSF
expression and phenotype. Both human and mouse ThGM cells can be readily differentiated directly from
naïve CD4+ T cells in vitro; however, it is unclear if ThGM cells in vivo originate from naïve precursors, or a
Th lineage that switched its phenotype. We hypothesize that ThGM cells in vivo develop directly from naïve
CD4+ T cells. In addition, we will study whether GM-CSF is a key determinant of ThGM cell phenotype, or
these cells have a unique overall phenotype irrespective of GM-CSF expression.
Aim 2. To study the role of ThGM cells in autoimmune neuroinflammation. Recent findings have
suggested that ThGM cells contribute to CNS autoimmunity, as they are overrepresented in MS patients’
PBMCs, and they induce EAE in mice by passive transfer. This led us to hypothesize that ThGM cells play
a significant pathogenic role in MS and EAE. In mice, we will characterize CNS autoimmunity induced by
ThGM cells, while in the human system we will test their pathogenicity in organotypic brain slices, and
characterize ThGM cells in MS brain lesions.
Aim 3. To determine the role of candidate TFs in shaping ThGM phenotype. ThGM cells do not express
master TFs of established Th lineages, suggesting that the ThGM phenotype is shaped by TF(s) differentially
expressed in ThGM cells. Our findings form the basis for the hypothesis that the ThGM phenotype is directed
by a set of TFs naturally overexpressed in ThGM cells compared to other Th cells. We will test this hypothesis
using mice lacking candidate TFs and by knocking down expression of candidate TFs in human CD4+ T cells.
Knowledge gained from these studies may modify the current concept of CNS autoimmunity.
中枢神经系统自身免疫中的 ThGM 细胞总结
ThGM 细胞 (ThGM-CSF) 是新描述的 Th 亚群,其特征是产生 GM-CSF,但是
缺乏已建立的 Th 细胞的标志性细胞因子和主转录因子 (TF) 的表达
血统。在我们的分析中,ThGM 细胞在血液中明显多于 Th2 和 Th17 细胞。
健康受试者,多发性硬化症患者更是如此。尽管 ThGM 细胞具有一些独特的特征
谱系,需要进一步研究来澄清这种区别,以及它们在健康和疾病中的作用。 ThGM细胞
在过继性 EAE 模型中具有高度致脑炎性,并且很容易在小鼠的中枢神经系统中发现它们
直接EAE。重要的是,多发性硬化症患者的脑脊液中富含 ThGM 细胞,这些患者也
与健康个体相比,具有更多数量的循环 ThGM 细胞。这些发现表明 ThGM
细胞有助于中枢神经系统自身免疫的发病机制,但这一主题的研究很少。超过
总之,我们的数据和已发表的研究结果使我们推测 ThGM 细胞发挥着重要的致病作用
自身免疫性神经炎症、MS 和 EAE。我们将在以下具体目标中检验这一假设:
目的 1. 确定 ThGM 细胞的起源,并表征其 GM-CSF 之间的关系
表达和表型。人类和小鼠 ThGM 细胞都可以很容易地直接从
体外幼稚 CD4+ T 细胞;然而,尚不清楚体内的 ThGM 细胞是否源自幼稚前体,或者是
改变其表型的谱系。我们假设 ThGM 细胞在体内直接从幼稚细胞发育而来
CD4+ T 细胞。此外,我们将研究 GM-CSF 是否是 ThGM 细胞表型的关键决定因素,或者
无论 GM-CSF 表达如何,这些细胞都具有独特的整体表型。
目的2.研究ThGM细胞在自身免疫性神经炎症中的作用。最近的研究结果有
表明 ThGM 细胞有助于中枢神经系统自身免疫,因为它们在多发性硬化症患者中的比例过高
PBMCs,它们通过被动转移诱导小鼠 EAE。这使我们推测 ThGM 细胞发挥作用
在 MS 和 EAE 中具有重要的致病作用。在小鼠中,我们将表征由以下因素引起的中枢神经系统自身免疫:
ThGM 细胞,而在人体系统中,我们将在器官型脑切片中测试其致病性,并且
表征多发性硬化症脑损伤中的 ThGM 细胞。
目标 3. 确定候选转录因子在塑造 ThGM 表型中的作用。 ThGM 细胞不表达
已建立的 Th 谱系的主要 TF,表明 ThGM 表型是由 TF 差异塑造的
在 ThGM 细胞中表达。我们的研究结果构成了 ThGM 表型是定向的假设的基础
与其他 Th 细胞相比,ThGM 细胞中自然过度表达的一组 TF。我们将检验这个假设
使用缺乏候选转录因子的小鼠并敲低人类 CD4+ T 细胞中候选转录因子的表达。
从这些研究中获得的知识可能会改变当前中枢神经系统自身免疫的概念。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A.M. Rostami其他文献
A.M. Rostami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A.M. Rostami', 18)}}的其他基金
IL-37: a novel regulator of inflammation in CNS autoimmunity
IL-37:中枢神经系统自身免疫炎症的新型调节剂
- 批准号:
10199564 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
IL-37: a novel regulator of inflammation in CNS autoimmunity
IL-37:中枢神经系统自身免疫炎症的新型调节剂
- 批准号:
10369694 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity
少突胶质细胞外囊泡:中枢神经系统自身免疫的新疗法
- 批准号:
10115612 - 财政年份:2020
- 资助金额:
$ 39万 - 项目类别:
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity
少突胶质细胞外囊泡:中枢神经系统自身免疫的新疗法
- 批准号:
10361415 - 财政年份:2020
- 资助金额:
$ 39万 - 项目类别:
Mechanisms of GM-CSF effect in CNS autoimmune demyelination
GM-CSF在中枢神经系统自身免疫性脱髓鞘中的作用机制
- 批准号:
10062792 - 财政年份:2016
- 资助金额:
$ 39万 - 项目类别:
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
GM-CSF 在多发性硬化症发病机制中的作用
- 批准号:
8767198 - 财政年份:2014
- 资助金额:
$ 39万 - 项目类别:
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
GM-CSF 在多发性硬化症发病机制中的作用
- 批准号:
8911388 - 财政年份:2014
- 资助金额:
$ 39万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:














{{item.name}}会员




